• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Cipla > November 05, 2005

      Cipla beats Ranbaxy, tops sales in September

      Posted AtEconomic Times

      Ending Ranbaxy Laboratories's run as the top-selling drug maker in the domestic retail market for the last three months, Cipla has topped the retail sales chart in September. According to the market research firm ORG IMS latest figures, during September, Cipla's sales grew 15.3% from last month, garnering 4.92% in the Rs 29,000 domestic retail market. In comparison, sales of India's largest drug maker Ranbaxy Laboratories by revenue (including overseas sales), grew marginally 0.9% with a market share of 4.81%.

      Ranbaxy Laboratories has been leading the sales for the last three months - June to August. GlaxoSmithkline is in the third position. India's largest company by market capitalisation, Sun Pharma, is in the 7th position with 3.08% while Hyderabad-based Dr Reddy's Laboratories, India's second-largest company by revenue (including overseas sales), lies at the 13th spot with 2.24%.

      For the nine-month period ended September, Cipla continues to maintain the top spot having pipped Ranbaxy Laboratories in May. ORG IMS figures are arrived at by collecting sales figures from around thousands of pharma retail centres across the country. The Indian domestic market is around Rs 35,000 crore and growing at 13% annually. Retail sales account for around Rs 29,000 crore while the rest comes from institutional sales.

      In the brands section, Pfizer's multivitamin Becosules emerged as the highest selling brand in the Indian market during the September raking in Rs 1.47 crore. Last month's highest selling cough syrup Corex, was down -18.9% from last month. Another cough syrup, Nicholas Piramal India Ltd's Phensedyl has taken the third spot. Himalaya Herbal Healthcare's liver tonic drug Liv 52, the only herbal drug in top 30 brands, is in the fourth position.

      For the nine-month period ended September, Novartis painkiller Voveran continues to retain the number 1 spot having taken over Corex recently.

      November 05, 2007


       

      Share this Article!

    Back to top^